Johnson & Johnson (JNJ)
178.57
-0.72 (-0.40%)
NYSE · Last Trade: Aug 25th, 12:27 PM EDT

Powell’s dovish Jackson Hole remarks signal that the Fed could cut rates as early as September, with markets now pricing an 80% chance of a 25 bps cut.
Via MarketBeat · August 25, 2025

Johnson & Johnson's strategic shift to a focused pharma and medtech model is fueling growth through a powerful drug pipeline and key acquisitions.
Via MarketBeat · August 25, 2025

Bridgewater's Q2 filing shows a full exit from Chinese stocks like Alibaba, as new management bets big on NVIDIA & JNJ. See all the shifts.
Via Benzinga · August 25, 2025
This Pharma Giant Is Set To Invest $2B To Expand Manufacturing In North Carolina, And It Just Received A Price Target Hike From Citi: Do You Own It?stocktwits.com
Via Stocktwits · August 21, 2025

If you're looking for income stocks, this trio of healthcare stocks is a great place to start with $500 (or $5,000).
Via The Motley Fool · August 25, 2025
Growth stocks are dominating the S&P 500, pushing the index's dividend yield to a 25-year low.
Via The Motley Fool · August 24, 2025
These healthcare giants can survive the toughest challenges.
Via The Motley Fool · August 24, 2025

Massive growth stocks are driving the performance of the S&P 500, for better or for worse.
Via The Motley Fool · August 24, 2025
Investors looking to double down on mega cap stocks like the "Ten Titans" may want to take a closer look at this low-cost ETF.
Via The Motley Fool · August 23, 2025
The US equity market in mid-2025 presents a complex and often contradictory landscape for investors. While the S&P 500 has flirted with all-time highs, fueled by optimistic economic data and the anticipation of interest rate adjustments, a closer look reveals a market grappling with elevated valuations, particularly within the
Via MarketMinute · August 22, 2025
The U.S. economy finds itself at a crossroads, grappling with a complex interplay of growth projections. Recent downward revisions for 2025, coupled with a notable contraction in the first quarter of the year, paint a cautious picture. However, this conservative outlook is sharply contrasted by more optimistic signals emanating
Via MarketMinute · August 22, 2025
Johnson & Johnson (NYSE: JNJ) is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing operations. This move comes in response to potential drug import tariffs proposed by the Trump administration.
Via Benzinga · August 22, 2025
Names you've heard of with track records to love.
Via The Motley Fool · August 21, 2025
Via Benzinga · August 21, 2025
Despite hovering at or near all-time highs, the major U.S. stock indices—the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite—have recently displayed a remarkably subdued daily performance. This period of consolidation, marked by narrow trading ranges and fractional movements, signals a market grappling with a
Via MarketMinute · August 19, 2025
The U.S. Treasury yield curve has contorted into a rare and unsettling U-shape, a configuration seen in only a fraction of the past five decades. This unusual curve, characterized by high short-term rates, a distinct dip in intermediate-term yields, and a subsequent rise for longer maturities, signals a profound
Via MarketMinute · August 19, 2025
Wall Street is currently gripped by a palpable "wait-and-see" sentiment, as investors adopt an overwhelmingly cautious stance ahead of Federal Reserve Chair Jerome Powell's highly anticipated speech at the Jackson Hole Symposium. This pervasive mood has led to muted trading activity across major indices, reflecting a deep-seated reluctance among market
Via MarketMinute · August 19, 2025
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.
Via Benzinga · August 18, 2025
Via Benzinga · August 18, 2025
The global financial landscape is currently navigating a period of heightened uncertainty, with key economic indicators signaling a notable deceleration in private consumption and emerging fragilities within the labor market. These intertwined trends are casting a long shadow over the stock market, prompting investors to re-evaluate their positions and brace
Via MarketMinute · August 18, 2025

These companies have successfully navigated similar obstacles before.
Via The Motley Fool · August 17, 2025